| HORŇÁK, Tomáš, Lukáš SEMERÁD, Daniela ŽÁČKOVÁ, Barbora WEINBERGEROVÁ, Zuzana ŠUSTKOVÁ, Jiřina PROCHÁZKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study. In Evropský Hematologický Sjezd, Stokholm, švédsko, 14-17.6.2018 in Abstract Book str.878. 2018. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1425556,
author = {Horňák, Tomáš and Semerád, Lukáš and Žáčková, Daniela and Weinbergerová, Barbora and Šustková, Zuzana and Procházková, Jiřina and Mayer, Jiří and Ráčil, Zdeněk},
booktitle = {Evropský Hematologický Sjezd, Stokholm, švédsko, 14-17.6.2018 in Abstract Book str.878.},
title = {Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study},
year = {2018}
}
TY - CONF
ID - 1425556
AU - Horňák, Tomáš - Semerád, Lukáš - Žáčková, Daniela - Weinbergerová, Barbora - Šustková, Zuzana - Procházková, Jiřina - Mayer, Jiří - Ráčil, Zdeněk
PY - 2018
TI - Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study
ER -
HORŇÁK, Tomáš, Lukáš SEMERÁD, Daniela ŽÁČKOVÁ, Barbora WEINBERGEROVÁ, Zuzana ŠUSTKOVÁ, Jiřina PROCHÁZKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Analysis of serum lipids, cardiovascular risk and indication for statin therapy at the start and during imatinib and nilotinib therapy in de novo CML patients, results from real life prosective study. In \textit{Evropský Hematologický Sjezd, Stokholm, švédsko, 14-17.6.2018 in Abstract Book str.878.}. 2018.
|
